Zentalis Pharmaceuticals, Inc. (ZNTL)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
5. 11
+0.54
+11.8162%
$
339.56M Market Cap
- P/E Ratio
- Div Yield
3.55M Volume
-3.66 Eps
$ 4.57
Previous Close 
Want to track ZNTL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
ZNTL Earnings Reports FAQ
What is the earnings per share (EPS) for ZNTL?
The current EPS is -3.66.
What is the company's earnings growth rate?
Zentalis Pharmaceuticals, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Zentalis Pharmaceuticals, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Zentalis Pharmaceuticals, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ZNTL at this time, as Zentalis Pharmaceuticals, Inc has no recent EPS data to calculate it.
